Sort
10,766 grants matching “checkpoint inhibitor”
Targeting Janus kinases in the treatment of autoimmune disease
$282,598John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
Biostatistics and Data Management
$282,592Haesook Kim · Dana-Farber Cancer Inst · P01 · FY2022 · CA
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS
$282,496Raymond E Meyn · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
Function of the ATR-ATRIP complex
$282,300David K Cortez · Vanderbilt University · R01 · FY2014 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$282,238Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2022 · CA
Project 4
$282,233Eva Hernando · New York University School Of Medicine · P50 · FY2019 · CA
Project 4
$282,230Eva Hernando · New York University School Of Medicine · P50 · FY2021 · CA
Project 4
$282,229Eva Hernando · New York University School Of Medicine · P50 · FY2022 · CA
Metnase, PIKK, and RPA Roles in DNA Damage and Replication Stress Responses
$282,172Jac A Nickoloff · Colorado State University · R01 · FY2013 · GM
Roles of DNA Ligase 1 in Mammalian DNA Metabolism
$282,170Alan E Tomkinson · University Of Maryland Baltimore · R01 · FY2010 · GM
Project 2
$282,099Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2019 · CA
Liver disease impact on myeloid cells driving immunotherapy resistance in hepatocellular carcinoma
$282,053Bridget Keenan · University Of California, San Francisco · K08 · FY2025 · CA
Islet Growth Factors Transgenic and Viral Modeling
$281,559Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · DK
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS
$281,477Raymond E Meyn · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Islet Growth Factors Transgenic and Viral Modeling
$281,256Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · DK
Roles of DNA Ligase 1 in Mammalian DNA Metabolism
$281,210Alan E Tomkinson · University Of New Mexico Health Scis Ctr · R01 · FY2012 · GM
Administrative/Clinical Trials Core
$281,193Kirby I Bland · University Of Alabama At Birmingham · P50 · FY2008 · CA
Project 1: Genomic Predictors of Clinical Outcomes and Response to Targeted Therapy in Advanced Prostate Cancer
$280,975David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Modulators of p53 Expression and Function
$280,880Andrei V Gudkov · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
Project 1
$280,878Jiyoung Ahn · New York University School Of Medicine · P50 · FY2022 · CA
PROTEOLYSIS AND MAMMALIAN GL/S CELL CYCLE TRANSITION
$280,728Yale University · R01 · FY2000 · CA
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA
$280,617Nelson Fausto · University Of Washington · R01 · FY2008 · CA
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA
$280,617Nelson Fausto · University Of Washington · R01 · FY2007 · CA
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA
$280,617Nelson Fausto · University Of Washington · R01 · FY2010 · CA
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA
$280,617Nelson Fausto · University Of Washington · R01 · FY2009 · CA